---
title: "Predicting In-Hospital Mortality at 72 Hours in ICU Patients with Sepsis and Hypertension"
id: "medrxiv-0-prediction-of-in-hospital-mortality-at-a-72-hour-intensive-care-landmark-in"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-0-prediction-of-in-hospital-mortality-at-a-72-hour-intensive-care-landmark-in"
content_type: "clinical_feed_article"
specialty: "Critical Care"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.10.02.26364566v1?rss=1"
published_at: "2026-10-06T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Predicting In-Hospital Mortality at 72 Hours in ICU Patients with Sepsis and Hypertension
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-0-prediction-of-in-hospital-mortality-at-a-72-hour-intensive-care-landmark-in
- **Specialty:** [Critical Care](https://medichelpline.com/clinical-feed/critical-care.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.10.02.26364566v1?rss=1)
- **Published At:** 2026-10-06T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- This retrospective study developed and externally validated a prediction model for **in-hospital mortality** at a 72-hour intensive care landmark in patients with **sepsis** and **pre-existing hypertension**. - Development used MIMIC-IV (n=1,019) and external validation used eICU-CRD (n=1,747). Observed deaths were 338 (33.2%) in development and 516 (29.5%) in external cohorts. - Eligible patients had received vasoactive agents and remained in the ICU for at least **72 hours**; static baseline variables were combined with dynamic features from six consecutive 12-hour windows covering the first 72 hours. - Data processing steps (imputation, feature selection, model fitting, calibration) were performed inside training folds during five-fold cross-validation; final model was an **XGBoost** classifier applied to the external set without refitting. - Internal discrimination: AUC 0.752 (95% CI 0.720–0.784). External discrimination: AUC 0.713 (95% CI 0.687–0.739); average precision 0.536; Brier score 0.185; calibration slope 0.744. - Risk stratification in the external cohort showed mortality rising across risk tertiles from 13.7% to 47.3%. - Exploratory comparison found the static-plus-dynamic feature set improved internal AUC by 0.071 (95% CI 0.042–0.109) versus static-only features. - Authors conclude accumulated information during the first 72 hours supports subsequent mortality risk stratification; model showed moderate external discrimination and could augment clinical reassessment, but requires local calibration and evaluation of clinical consequences before routine use. - The study is a secondary analysis of de-identified MIMIC-IV and eICU-CRD databases; no new patient-level data were generated and the preprint has not been peer reviewed.
## Clinical Analysis & Structured Key Points
[](https://www.medrxiv.org/cdn-cgi/content?id=FRRuG9jnt_pn_wj7PyR40EfZj2tj6utooghK6qm72Tk-1791301970.6466768-1.2.1.1-jkKiJWVBFzXlroh2B.t_IxJ6U9eYQ2_0CLh7nGxHs.7DAVvaQ60WijOmS0ERlDGg) [Skip to main content](https://www.medrxiv.org/content/10.64898/2026.10.02.26364566v1?rss=1#main-content) [![medRxiv](https://www.medrxiv.org/sites/default/files/medrxiv_inner_logo.png)](https://www.medrxiv.org/) * [Home](https://www.medrxiv.org/) * [Submit](https://www.medrxiv.org/submit-a-manuscript) * [FAQ](https://www.medrxiv.org/about/FAQ) * [Blog](https://connect.medrxiv.org/news/) * [ALERTS / RSS](https://www.medrxiv.org/content/alertsrss) * [Resources](https://connect.medrxiv.org/resources/) * [About](https://www.medrxiv.org/content/about-medrxiv) Search for this keyword [Advanced Search](https://www.medrxiv.org/search) Follow this preprint # Prediction of in-hospital mortality at a 72-hour intensive care landmark in patients with sepsis and pre-existing hypertension: development and external validation Yufeng Chen, Yuzhen Cai, Hongyang Bian, Mingyan Fu doi: https://doi.org/10.64898/2026.10.02.26364566 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Yufeng Chen 1 Shandong Provincial Public Health Clinical Center: Shandong Provincial Chest Hospital; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Yufeng%2BChen%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Chen%20Y&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AYufeng%2BChen%2B) * For correspondence: 314630069@qq.com Yuzhen Cai 2 Shandong Provincial Public Health Clinical Center * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Yuzhen%2BCai%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Cai%20Y&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AYuzhen%2BCai%2B) Hongyang Bian 2 Shandong Provincial Public Health Clinical Center * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Hongyang%2BBian%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Bian%20H&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AHongyang%2BBian%2B) Mingyan Fu 2 Shandong Provincial Public Health Clinical Center * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Mingyan%2BFu%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Fu%20M&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AMingyan%2BFu%2B) * [Abstract](https://www.medrxiv.org/content/10.64898/2026.10.02.26364566v1)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_art/node:1314707/1) * [Info/History](https://www.medrxiv.org/content/10.64898/2026.10.02.26364566v1.article-info)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_info/node:1314707/1) * [Metrics](https://www.medrxiv.org/content/10.64898/2026.10.02.26364566v1.article-metrics)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_metrics/node:1314707/1) * [Data/Code](https://www.medrxiv.org/content/10.64898/2026.10.02.26364566v1.external-links)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_data_code/node:1314707/1) * [ Preview PDF](https://www.medrxiv.org/content/10.64898/2026.10.02.26364566v1.full.pdf+html)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:1314707/1) ![Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Abstract Background: In patients with sepsis and pre-existing hypertension, admission findings may not adequately describe the subsequent course of circulatory support and organ dysfunction. We developed and externally validated a model to reassess in-hospital mortality risk after the first 72 hours of intensive care. Methods: This retrospective study used MIMIC-IV for development and eICU-CRD for external validation. Patients had received vasoactive agents and remained in the ICU for at least 72 hours. Static variables were combined with features from six consecutive 12-hour windows. Imputation, feature selection, model fitting, and calibration were performed within training folds during five-fold cross-validation. The final XGBoost model was applied externally without refitting. Evaluation included discrimination, calibration, decision curves, and risk stratification, with an exploratory comparison of static-only and static-plus-dynamic feature sets. Results: The development and external cohorts included 1019 and 1747 patients, with 338 (33.2%) and 516 (29.5%) deaths, respectively. Internal area under the receiver operating characteristic curve (AUC) was 0.752 (95% CI 0.720–0.784). External AUC was 0.713 (95% CI 0.687–0.739), average precision was 0.536, the Brier score was 0.185, and the calibration slope was 0.744. Mortality increased across external risk tertiles from 13.7% to 47.3%. In an exploratory feature-set comparison, the static-plus-dynamic feature set showed a 0.071 higher internal AUC than the static feature set (95% CI 0.042–0.109). Conclusions: Information accumulated during the first 72 hours supported subsequent mortality risk stratification in this selected population. The model retained moderate discrimination externally, supporting further evaluation as an adjunct to clinical reassessment. Local calibration and the clinical consequences of acting on model predictions require evaluation before routine use. ### Competing Interest Statement The authors have declared no competing interest. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: The collection of patient information and creation of the MIMIC-IV research resource were reviewed by the Institutional Review Board of Beth Israel Deaconess Medical Center, which approved the data-sharing initiative and granted a waiver of individual informed consent. The eICU Collaborative Research Database contains de-identified data meeting the HIPAA Safe Harbor standard and is available to credentialed researchers through PhysioNet after completion of the required human-subjects research training and data use agreement. The present study was a secondary analysis of these de-identified databases, involved no patient contact or access to identifiable information, and therefore did not require separate ethics approval or individual informed consent. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes ## Data Availability No new patient-level data were generated by this study. The data analyzed in this study were obtained from two existing databases available through PhysioNet: MIMIC-IV version 3.1 (https://doi.org/10.13026/kpb9-mt58) and the eICU Collaborative Research Database version 2.0 (https://doi.org/10.13026/C2WM1R). Access to these databases requires completion of the applicable PhysioNet credentialing process, training, and data use agreements. The authors did not receive any special privileges in accessing these data, and other qualified researchers can obtain access under the same conditions through PhysioNet. Because the patient-level data are subject to PhysioNet data use agreements, the authors are not permitted to redistribute them. Aggregate results underlying the reported findings are provided in the manuscript and Supporting Information. Author-generated analysis code and reproduction instructions will be made publicly available upon publication. Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a [CC-BY 4.0 International license](http://creativecommons.org/licenses/by/4.0/). bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.medrxiv.org/content/10.64898/2026.10.02.26364566v1?rss=1#page) [ Previous](https://www.medrxiv.org/content/10.64898/2026.10.02.26364565v1 "Predicting Cervical Cancer Screening Utilization Among Women of Reproductive Age in Ethiopia Using Supervised Machine Learning: A Nationally Representative 2024/25 EDHS Study")[Next ](https://www.medrxiv.org/content/10.64898/2026.10.03.26364638v1 "Pallidal Local Field Potentials markers of dystonia aetiology and severity in children") Posted October 06, 2026. [ Download PDF](https://www.medrxiv.org/content/10.64898/2026.10.02.26364566v1.full.pdf) Print/Save Options [Download PDF](https://www.medrxiv.org/content/medrxiv/early/2026/10/06/2026.10.02.26364566.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.medrxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Author Declarations](https://www.medrxiv.org/content/10.64898/2026.10.02.26364566v1#p-5) [ Data/Code](https://www.medrxiv.org/content/early/2026/10/06/2026.10.02.26364566.external-links) [ Email](https://www.medrxiv.org/ "Email this Article") [ Share](https://www.medrxiv.org/) Prediction of in-hospital mortality at a 72-hour intensive care landmark in patients with sepsis and pre-existing hypertension: development and external validation Yufeng Chen, Yuzhen Cai, Hongyang Bian, Mingyan Fu medRxiv 2026.10.02.26364566; doi: https://doi.org/10.64898/2026.10.02.26364566 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Share This Article: Copy [![Twitter logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.medrxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.10.02.26364566v1%26text%3DPrediction%2520of%2520in-hospital%2520mortality%2520at%2520a%252072-hour%2520intensive%2520care%2520landmark%2520in%2520patients%2520with%2520sepsis%2520and%2520pre-existing%2520hypertension%253A%2520development%2520and%2520external%2520validation "Share this on Twitter") [![Facebook logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.medrxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.10.02.26364566v1%26t%3DPrediction%2520of%2520in-hospital%2520mortality%2520at%2520a%252072-hour%2520intensive%2520care%2520landmark%2520in%2520patients%2520with%2520sepsis%2520and%2520pre-existing%2520hypertension%253A%2520development%2520and%2520external%2520validation "Share on Facebook") [![LinkedIn logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.medrxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.10.02.26364566v1%26title%3DPrediction%2520of%2520in-hospital%2520mortality%2520at%2520a%252072-hour%2520intensive%2520care%2520landmark%2520in%2520patients%2520with%2520sepsis%2520and%2520pre-existing%2520hypertension%253A%2520development%2520and%2520external%2520validation%26summary%3D%26source%3DmedRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.medrxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.10.02.26364566v1%26title%3DPrediction%2520of%2520in-hospital%2520mortality%2520at%2520a%252072-hour%2520intensive%2520care%2520landmark%2520in%2520patients%2520with%2520sepsis%2520and%2520pre-existing%2520hypertension%253A%2520development%2520and%2520external%2520validation "Share on Mendeley") [ Citation Tools](https://www.medrxiv.org/ "Citation Tools") [ Get QR code](https://connect.medrxiv.org/qr/2026.10.02.26364566) * [Tweet Widget](http://twitter.com/share?url=https%3A//www.medrxiv.org/content/10.64898/2026.10.02.26364566v1&count=horizontal&via=&text=Prediction%20of%20in-hospital%20mortality%20at%20a%2072-hour%20intensive%20care%20landmark%20in%20patients%20with%20sepsis%20and%20pre-existing%20hypertension%3A%20development%20and%20external%20validation&counturl=www.medrxiv.org/content/10.64898/2026.10.02.26364566v1 "Tweet This") ## Subject Area * [Intensive Care and Critical Care Medicine ](https://www.medrxiv.org/collection/intensive-care-and-critical-care-medicine) Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.medrxiv.org/content/early/recent) * [Addiction Medicine](https://www.medrxiv.org/collection/addiction-medicine) (626) * [Allergy and Immunology](https://www.medrxiv.org/collection/allergy-and-immunology) (914) * [Anesthesia](https://www.medrxiv.org/collection/anesthesia) (340) * [Cardiovascular Medicine](https://www.medrxiv.org/collection/cardiovascular-medicine) (4885) * [Dentistry and Oral Medicine](https://www.medrxiv.org/collection/dentistry-and-oral-medicine) (486) * [Dermatology](https://www.medrxiv.org/collection/dermatology) (421) * [Emergency Medicine](https://www.medrxiv.org/collection/emergency-medicine) (659) * [Endocrinology (including Diabetes Mellitus and Metabolic Disease)](https://www.medrxiv.org/collection/endocrinology-including-diabetes-mellitus-and-metabolic-disease) (1644) * [Epidemiology](https://www.medrxiv.org/collection/epidemiology) (16067) * [Forensic Medicine](https://www.medrxiv.org/collection/forensic-medicine) (34) * [Gastroenterology](https://www.medrxiv.org/collection/gastroenterology) (1218) * [Genetic and Genomic Medicine](https://www.medrxiv.org/collection/genetic-and-genomic-medicine) (7129) * [Geriatric Medicine](https://www.medrxiv.org/collection/geriatric-medicine) (737) * [Health Economics](https://www.medrxiv.org/collection/health-economics) (1073) * [Health Informatics](https://www.medrxiv.org/collection/health-informatics) (5125) * [Health Policy](https://www.medrxiv.org/collection/health-policy) (1447) * [Health Systems and Quality Improvement](https://www.medrxiv.org/collection/health-systems-and-quality-improvement) (1793) * [Hematology](https://www.medrxiv.org/collection/hematology) (590) * [HIV/AIDS](https://www.medrxiv.org/collection/hiv-aids) (1355) * [Infectious Diseases (except HIV/AIDS)](https://www.medrxiv.org/collection/infectious_diseases) (16360) * [Intensive Care and Critical Care Medicine](https://www.medrxiv.org/collection/intensive-care-and-critical-care-medicine) (1185) * [Medical Education](https://www.medrxiv.org/collection/medical-education) (678) * [Medical Ethics](https://www.medrxiv.org/collection/medical-ethics) (156) * [Nephrology](https://www.medrxiv.org/collection/nephrology) (729) * [Neurology](https://www.medrxiv.org/collection/neurology) (7388) * [Nursing](https://www.medrxiv.org/collection/nursing) (370) * [Nutrition](https://www.medrxiv.org/collection/nutrition) (1102) * [Obstetrics and Gynecology](https://www.medrxiv.org/collection/obstetrics-and-gynecology) (1263) * [Occupational and Environmental Health](https://www.medrxiv.org/collection/occupational-and-environmental-health) (1010) * [Oncology](https://www.medrxiv.org/collection/oncology) (3659) * [Ophthalmology](https://www.medrxiv.org/collection/ophthalmology) (1066) * [Orthopedics](https://www.medrxiv.org/collection/orthopedics) (399) * [Otolaryngology](https://www.medrxiv.org/collection/otolaryngology) (460) * [Pain Medicine](https://www.medrxiv.org/collection/pain-medicine) (483) * [Palliative Medicine](https://www.medrxiv.org/collection/palliative-medicine) (142) * [Pathology](https://www.medrxiv.org/collection/pathology) (711) * [Pediatrics](https://www.medrxiv.org/collection/pediatrics) (1823) * [Pharmacology and Therapeutics](https://www.medrxiv.org/collection/pharmacology-and-therapeutics) (741) * [Primary Care Research](https://www.medrxiv.org/collection/primary-care-research) (777) * [Psychiatry and Clinical Psychology](https://www.medrxiv.org/collection/psychiatry-and-clinical-psychology) (5988) * [Public and Global Health](https://www.medrxiv.org/collection/public-and-global-health) (9836) * [Radiology and Imaging](https://www.medrxiv.org/collection/radiology-and-imaging) (2465) * [Rehabilitation Medicine and Physical Therapy](https://www.medrxiv.org/collection/rehabilitation-medicine-and-physical-therapy) (1479) * [Respiratory Medicine](https://www.medrxiv.org/collection/respiratory-medicine) (1257) * [Rheumatology](https://www.medrxiv.org/collection/rheumatology) (651) * [Sexual and Reproductive Health](https://www.medrxiv.org/collection/sexual-and-reproductive-health) (786) * [Sports Medicine](https://www.medrxiv.org/collection/sports-medicine) (588) * [Surgery](https://www.medrxiv.org/collection/surgery) (786) * [Toxicology](https://www.medrxiv.org/collection/toxicology) (107) * [Transplantation](https://www.medrxiv.org/collection/transplantation) (310) * [Urology](https://www.medrxiv.org/collection/urology) (298) Evaluation/discussion of this paper x Comments 0TRiP 0Community 0Automated 0Blogs/Media 0Video 0 Comments medRxiv aims to provide a venue for anyone to comment on a medRxiv preprint. Comments are moderated for offensiv
## Related Clinical Research

- [Antenatal Interventions to Improve Newborn Survival: LiST Model Updates](https://medichelpline.com/clinical-feed/pubmed-42825345.md) (DOI: 10.7189/jogh.16.04303)
- [Diabetes and ASCVD Alter the Link Between sTNFR1 Levels and Sepsis Mortality](https://medichelpline.com/clinical-feed/pubmed-42813914.md) (DOI: 10.1097/CCM.0000000000007374)
- [Plasma metabolomic profiling reveals candidate biomarkers for sepsis diagnosis and mortality predi](https://medichelpline.com/clinical-feed/frontiers-in-immunology-18-plasma-metabolomic-profiling-identifies-candidate-biomarkers-associated-with.md)
- [mNGS-negative Strongyloides Hyperinfection Syndrome Presenting as Small Bowel Obstruction in a Glu](https://medichelpline.com/clinical-feed/frontiers-in-immunology-13-case-report-mngs-negative-strongyloides-hyperinfection-syndrome-with-small.md)
- [Frailty prediction in heart failure with acute infection: role of thiazide diuretics and an interp](https://medichelpline.com/clinical-feed/plos-one-9-frailty-prediction-in-heart-failure-patients-with-acute-infections-the.md)

## Navigation
- [← Back to Critical Care Feed](https://medichelpline.com/clinical-feed/critical-care.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.